Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 187

1.

Relationship between protein-energy wasting in adults with chronic hemodialysis and the response to treatment with erythropoietin.

González-Ortiz A, Correa-Rotter R, Vázquez-Rangel A, Vega-Vega O, Espinosa-Cuevas Á.

BMC Nephrol. 2019 Aug 14;20(1):316. doi: 10.1186/s12882-019-1457-0.

2.

Mesoamerican Nephropathy.

Correa-Rotter R, García-Trabanino R.

Semin Nephrol. 2019 May;39(3):263-271. doi: 10.1016/j.semnephrol.2019.02.004. Review.

PMID:
31054625
3.

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators.

Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Erratum in: Lancet. 2019 May 11;393(10184):1936.

PMID:
30995972
4.

Cholecalciferol supplementation increases FGF23 in peritoneal dialysis patients with hypovitaminosis D: a randomized clinical trial.

Ramirez-Sandoval JC, Arvizu-Hernandez M, Cruz C, Vazquez-Cantu B, Rojas-Concha LJ, Tamez L, Reynerio F, Gomez FE, Correa-Rotter R.

J Nephrol. 2019 Aug;32(4):645-659. doi: 10.1007/s40620-019-00599-x. Epub 2019 Mar 19.

PMID:
30888584
5.

Calcineurin Inhibitors With Reduced-Dose Steroids as First-Line Therapy for Focal Segmental Glomerulosclerosis.

Chávez-Mendoza CA, Niño-Cruz JA, Correa-Rotter R, Uribe-Uribe NO, Mejía-Vilet JM.

Kidney Int Rep. 2018 Aug 31;4(1):40-47. doi: 10.1016/j.ekir.2018.08.010. eCollection 2019 Jan.

6.

New 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline.

Martínez-Rueda AJ, Olivas-Martínez A, Vega-Vega O, Fonseca-Correa JI, Correa-Rotter R.

Hypertension. 2019 Jan;73(1):142-147. doi: 10.1161/HYPERTENSIONAHA.118.11827.

PMID:
30571542
7.

Kidney disease in Latin America: current status, challenges, and the role of the ISN in the development of nephrology in the region.

Pecoits-Filho R, Sola L, Correa-Rotter R, Claure-Del Granado R, Douthat WG, Bellorin-Font E; International Society of Nephrology Regional Board.

Kidney Int. 2018 Dec;94(6):1069-1072. doi: 10.1016/j.kint.2018.07.026. No abstract available.

PMID:
30466564
8.

[Development of a screening tool for a high sodium intake in an adult Mexican population].

Miranda Alatriste PV, Ramírez EC, Guillén Hernández M, Rivera Mancía S, Cartas Rosado R, Espinosa-Cuevas Á, Correa-Rotter R, Vallejo M.

Nutr Hosp. 2018 Oct 5;35(5):1163-1173. doi: 10.20960/nh.1789. Spanish.

9.

Comment on "Clinical Practice Guidelines for the Treatment of Systemic Lupus Erythematosus by the Mexican College of Rheumatology".

Mejia-Vilet JM, Tejeda-Maldonado J, Correa-Rotter R.

Reumatol Clin. 2018 Sep 19. pii: S1699-258X(18)30170-0. doi: 10.1016/j.reuma.2018.07.011. [Epub ahead of print] English, Spanish. No abstract available.

10.

Mortality in Patients With Chronic Renal Disease Without Health Insurance in Mexico: Opportunities for a National Renal Health Policy.

Valdez-Ortiz R, Navarro-Reynoso F, Olvera-Soto MG, Martin-Alemañy G, Rodríguez-Matías A, Hernández-Arciniega CR, Cortes-Pérez M, Chávez-López E, García-Villalobos G, Hinojosa-Heredia H, Camacho-Aguirre AY, Valdez-Ortiz Á, Cantú-Quintanilla G, Gómez-Guerrero I, Reding A, Pérez-Navarro M, Obrador G, Correa-Rotter R.

Kidney Int Rep. 2018 Jun 20;3(5):1171-1182. doi: 10.1016/j.ekir.2018.06.004. eCollection 2018 Sep.

11.

Contemporary Dietary Intake: Too Much Sodium, Not Enough Potassium, yet Sufficient Iodine: The SALMEX Cohort Results.

Vega-Vega O, Fonseca-Correa JI, Mendoza-De la Garza A, Rincón-Pedrero R, Espinosa-Cuevas A, Baeza-Arias Y, Dary O, Herrero-Bervera B, Nieves-Anaya I, Correa-Rotter R.

Nutrients. 2018 Jun 25;10(7). pii: E816. doi: 10.3390/nu10070816.

12.

Long-term survival of kidney grafts in lupus nephritis: a Mexican cohort.

Ramirez-Sandoval JC, Chavez-Chavez H, Wagner M, Vega-Vega O, Morales-Buenrostro LE, Correa-Rotter R.

Lupus. 2018 Jul;27(8):1303-1311. doi: 10.1177/0961203318770527. Epub 2018 Apr 26.

PMID:
29697013
13.

Baseline characteristics and enrichment results from the SONAR trial.

Heerspink HJL, Andress DL, Bakris G, Brennan JJ, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray J, Perkovic V, Tobe S, Wigderson M, Yi T, Parving HH, de Zeeuw D.

Diabetes Obes Metab. 2018 Aug;20(8):1829-1835. doi: 10.1111/dom.13315. Epub 2018 May 1.

14.

Relationship between Nutritional Status and Gastrointestinal Symptoms in Geriatric Patients with End-Stage Renal Disease on Dialysis.

Carrera-Jiménez D, Miranda-Alatriste P, Atilano-Carsi X, Correa-Rotter R, Espinosa-Cuevas Á.

Nutrients. 2018 Mar 29;10(4). pii: E425. doi: 10.3390/nu10040425.

15.

Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy.

Heerspink HJL, Andress DL, Bakris G, Brennan JJ, Correa-Rotter R, Dey J, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray J, Perkovic V, Tobe S, Wigderson M, Parving HH, de Zeeuw D.

Diabetes Obes Metab. 2018 Jun;20(6):1369-1376. doi: 10.1111/dom.13245. Epub 2018 Mar 9.

16.

Chronic kidney disease after acute kidney injury associated with intravenous colistin use in survivors of severe infections: A comparative cohort study.

Meraz-Muñoz A, Gomez-Ruiz I, Correa-Rotter R, Ramirez-Sandoval JC.

J Crit Care. 2018 Apr;44:244-248. doi: 10.1016/j.jcrc.2017.11.022. Epub 2017 Nov 15.

PMID:
29175613
17.

Circulating Concentrations of Advanced Glycation end Products, its Association With the Development of Diabetes Mellitus.

Jiménez IU, Díaz-Díaz E, Castro JS, Ramos JP, León MC, Alvarado Ríos JA, Auriostigue Bautista JC, Correa-Rotter R, Aguilar Salinas CA, Larrea F.

Arch Med Res. 2017 May;48(4):360-369. doi: 10.1016/j.arcmed.2017.07.001.

PMID:
29157674
18.

Combined assessment of nutritional status in patients with peritoneal dialysis using bioelectrical impedance vectors and malnutrition inflammation score.

Muñoz-Pérez E, Espinosa-Cuevas MLÁ, Miranda-Alatriste PV, Correa-Rotter R, Atilano-Carsi X.

Nutr Hosp. 2017 Oct 24;34(5):1125-1132. doi: 10.20960/nh.890.

19.

Genetic and environmental risk factors for chronic kidney disease.

Obrador GT, Schultheiss UT, Kretzler M, Langham RG, Nangaku M, Pecoits-Filho R, Pollock C, Rossert J, Correa-Rotter R, Stenvinkel P, Walker R, Yang CW, Fox CS, Köttgen A.

Kidney Int Suppl (2011). 2017 Oct;7(2):88-106. doi: 10.1016/j.kisu.2017.07.004. Epub 2017 Sep 20. Review.

20.

Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial.

Webb DJ, Coll B, Heerspink HJL, Andress D, Pritchett Y, Brennan JJ, Houser M, Correa-Rotter R, Kohan D, Makino H, Perkovic V, Remuzzi G, Tobe SW, Toto R, Busch R, Pergola P, Parving HH, de Zeeuw D.

Drugs R D. 2017 Sep;17(3):441-448. doi: 10.1007/s40268-017-0201-0.

21.

Food Sources of Sodium Intake in an Adult Mexican Population: A Sub-Analysis of the SALMEX Study.

Colin-Ramirez E, Espinosa-Cuevas Á, Miranda-Alatriste PV, Tovar-Villegas VI, Arcand J, Correa-Rotter R.

Nutrients. 2017 Jul 27;9(8). pii: E810. doi: 10.3390/nu9080810.

22.

Simple risk score for prediction of haemorrhagic complications after a percutaneous renal biopsy.

Mejía-Vilet JM, Márquez-Martínez MA, Cordova-Sanchez BM, Ibargüengoitia MC, Correa-Rotter R, Morales-Buenrostro LE.

Nephrology (Carlton). 2018 Jun;23(6):523-529. doi: 10.1111/nep.13055.

PMID:
28419667
23.

Prognostic significance of renal vascular pathology in lupus nephritis.

Mejía-Vilet JM, Córdova-Sánchez BM, Uribe-Uribe NO, Correa-Rotter R, Morales-Buenrostro LE.

Lupus. 2017 Sep;26(10):1042-1050. doi: 10.1177/0961203317692419. Epub 2017 Feb 8.

PMID:
28178879
24.

International Collaboration for the Epidemiology of eGFR in Low and Middle Income Populations - Rationale and core protocol for the Disadvantaged Populations eGFR Epidemiology Study (DEGREE).

Caplin B, Jakobsson K, Glaser J, Nitsch D, Jha V, Singh A, Correa-Rotter R, Pearce N.

BMC Nephrol. 2017 Jan 3;18(1):1. doi: 10.1186/s12882-016-0417-1.

25.

The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy.

Pena MJ, de Zeeuw D, Andress D, Brennan JJ, Correa-Rotter R, Coll B, Kohan DE, Makino H, Perkovic V, Remuzzi G, Tobe SW, Toto R, Parving HH, Sharma S, Corringham T, Sharma K, Heerspink HJL.

Diabetes Obes Metab. 2017 May;19(5):749-753. doi: 10.1111/dom.12864. Epub 2017 Feb 22.

PMID:
28019071
26.

Comparison of exposure response relationship of atrasentan between North American and Asian populations.

Heerspink HJ, Makino H, Andress D, Brennan JJ, Correa-Rotter R, Coll B, Davis JW, Idler K, Kohan DE, Liu M, Perkovic V, Remuzzi G, Tobe SW, Toto R, Parving HH, de Zeeuw D.

Diabetes Obes Metab. 2017 Apr;19(4):545-552. doi: 10.1111/dom.12851. Epub 2017 Jan 27.

PMID:
27981738
27.

Heat stress, hydration and uric acid: a cross-sectional study in workers of three occupations in a hotspot of Mesoamerican nephropathy in Nicaragua.

Wesseling C, Aragón A, González M, Weiss I, Glaser J, Rivard CJ, Roncal-Jiménez C, Correa-Rotter R, Johnson RJ.

BMJ Open. 2016 Dec 8;6(12):e011034. doi: 10.1136/bmjopen-2016-011034. Erratum in: BMJ Open. 2017 Jan 25;7(1):e011034corr1.

28.

Dissonant health transition in the states of Mexico, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Gómez-Dantés H, Fullman N, Lamadrid-Figueroa H, Cahuana-Hurtado L, Darney B, Avila-Burgos L, Correa-Rotter R, Rivera JA, Barquera S, González-Pier E, Aburto-Soto T, de Castro EF, Barrientos-Gutiérrez T, Basto-Abreu AC, Batis C, Borges G, Campos-Nonato I, Campuzano-Rincón JC, de Jesús Cantoral-Preciado A, Contreras-Manzano AG, Cuevas-Nasu L, de la Cruz-Gongora VV, Diaz-Ortega JL, de Lourdes García-García M, Garcia-Guerra A, de Cossío TG, González-Castell LD, Heredia-Pi I, Hijar-Medina MC, Jauregui A, Jimenez-Corona A, Lopez-Olmedo N, Magis-Rodríguez C, Medina-Garcia C, Medina-Mora ME, Mejia-Rodriguez F, Montañez JC, Montero P, Montoya A, Moreno-Banda GL, Pedroza-Tobías A, Pérez-Padilla R, Quezada AD, Richardson-López-Collada VL, Riojas-Rodríguez H, Ríos Blancas MJ, Razo-Garcia C, Mendoza MP, Sánchez-Pimienta TG, Sánchez-Romero LM, Schilmann A, Servan-Mori E, Shamah-Levy T, Téllez-Rojo MM, Texcalac-Sangrador JL, Wang H, Vos T, Forouzanfar MH, Naghavi M, Lopez AD, Murray CJ, Lozano R.

Lancet. 2016 Nov 12;388(10058):2386-2402. doi: 10.1016/S0140-6736(16)31773-1. Epub 2016 Oct 5.

PMID:
27720260
29.

Clinical, Dialytic, and Laboratory Factors Associated With Poor Health-Related Quality of Life in Mexican Patients on Hemodialysis.

Dehesa-López E, Correa-Rotter R, Olvera-Castillo D, González-Parra C, Baizabal-Olarte R.

Rev Invest Clin. 2016 Jul-Aug;68(4):192-200.

30.

In reply to: "Should we consider renaming 'Mesoamerican Nephropathy' as Nephropathy of Unknown Cause in Agricultural Labourers (NUCAL)?"

García-Trabanino R, Jakobsson K, Guzmán Quilo C, Brooks DR, Crowe J, Barnoya J, Madero M, González Quiroz M, Wesseling C, Wegman DH, Correa-Rotter R.

Occup Environ Med. 2016 Nov;73(11):802-803. doi: 10.1136/oemed-2016-104005. Epub 2016 Aug 26. No abstract available.

PMID:
27566784
31.
32.

Immunosuppressive treatment for pure membranous lupus nephropathy in a Hispanic population.

Mejía-Vilet JM, Córdova-Sánchez BM, Uribe-Uribe NO, Correa-Rotter R.

Clin Rheumatol. 2016 Sep;35(9):2219-27. doi: 10.1007/s10067-016-3366-y. Epub 2016 Jul 30.

PMID:
27475791
33.

Renal Thrombotic Microangiopathy in Proliferative Lupus Nephritis: Risk Factors and Clinical Outcomes: A Case-Control Study.

Barrera-Vargas A, Rosado-Canto R, Merayo-Chalico J, Arreola-Guerra JM, Mejía-Vilet JM, Correa-Rotter R, Gómez-Martín D, Alcocer-Varela J.

J Clin Rheumatol. 2016 Aug;22(5):235-40. doi: 10.1097/RHU.0000000000000425.

PMID:
27464767
34.

Transcultural adaptation and validation of the Mexican version of the kidney disease questionnaire KDQOL-SF36 version 1.3.

Dehesa-López E, Correa-Rotter R, Olvera-Castillo D, González-Parra C, Baizabal-Olarte R, Orozco-Vega R.

Qual Life Res. 2017 Jan;26(1):193-198. doi: 10.1007/s11136-016-1365-8. Epub 2016 Jul 14.

PMID:
27416832
35.

Climate Change and the Emergent Epidemic of CKD from Heat Stress in Rural Communities: The Case for Heat Stress Nephropathy.

Glaser J, Lemery J, Rajagopalan B, Diaz HF, García-Trabanino R, Taduri G, Madero M, Amarasinghe M, Abraham G, Anutrakulchai S, Jha V, Stenvinkel P, Roncal-Jimenez C, Lanaspa MA, Correa-Rotter R, Sheikh-Hamad D, Burdmann EA, Andres-Hernando A, Milagres T, Weiss I, Kanbay M, Wesseling C, Sánchez-Lozada LG, Johnson RJ.

Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1472-83. doi: 10.2215/CJN.13841215. Epub 2016 May 5. Review.

36.

Bicarbonate Values for Healthy Residents Living in Cities Above 1500 Meters of Altitude: A Theoretical Model and Systematic Review.

Ramirez-Sandoval JC, Castilla-Peón MF, Gotés-Palazuelos J, Vázquez-García JC, Wagner MP, Merelo-Arias CA, Vega-Vega O, Rincón-Pedrero R, Correa-Rotter R.

High Alt Med Biol. 2016 Jun;17(2):85-92. doi: 10.1089/ham.2015.0097. Epub 2016 Apr 27. Review.

PMID:
27120676
37.

Kidney function in sugarcane cutters in Nicaragua--A longitudinal study of workers at risk of Mesoamerican nephropathy.

Wesseling C, Aragón A, González M, Weiss I, Glaser J, Bobadilla NA, Roncal-Jiménez C, Correa-Rotter R, Johnson RJ, Barregard L.

Environ Res. 2016 May;147:125-32. doi: 10.1016/j.envres.2016.02.002. Epub 2016 Feb 8.

38.

Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement.

Córdova-Sánchez BM, Mejía-Vilet JM, Morales-Buenrostro LE, Loyola-Rodríguez G, Uribe-Uribe NO, Correa-Rotter R.

Clin Rheumatol. 2016 Jul;35(7):1805-16. doi: 10.1007/s10067-016-3195-z. Epub 2016 Feb 6.

PMID:
26852317
39.

Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis.

Parfrey PS, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Chertow GM.

Clin J Am Soc Nephrol. 2016 Mar 7;11(3):539-46. doi: 10.2215/CJN.06370615. Epub 2015 Nov 27. Review.

40.

Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial.

Pun PH, Abdalla S, Block GA, Chertow GM, Correa-Rotter R, Dehmel B, Drüeke TB, Floege J, Goodman WG, Herzog CA, London GM, Mahaffey KW, Moe SM, Parfrey PS, Wheeler DC, Middleton JP.

Hemodial Int. 2016 Jul;20(3):421-31. doi: 10.1111/hdi.12382. Epub 2015 Nov 13.

41.

Creatinine Versus Cystatin C for Estimating GFR in Patients With Liver Cirrhosis.

Torre A, Aguirre-Valadez JM, Arreola-Guerra JM, García-Flores OR, García-Juárez I, Cruz-Rivera C, Correa-Rotter R, Niño-Cruz JA.

Am J Kidney Dis. 2016 Feb;67(2):342-4. doi: 10.1053/j.ajkd.2015.09.022. Epub 2015 Oct 31. No abstract available.

PMID:
26530874
42.

Renal flare prediction and prognosis in lupus nephritis Hispanic patients.

Mejía-Vilet JM, Córdova-Sánchez BM, Arreola-Guerra JM, Morales-Buenrostro LE, Uribe-Uribe NO, Correa-Rotter R.

Lupus. 2016 Mar;25(3):315-24. doi: 10.1177/0961203315606985. Epub 2015 Sep 24.

PMID:
26405028
43.

Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.

Mejía-Vilet JM, Arreola-Guerra JM, Córdova-Sánchez BM, Morales-Buenrostro LE, Uribe-Uribe NO, Correa-Rotter R.

J Rheumatol. 2015 Nov;42(11):2082-91. doi: 10.3899/jrheum.150395. Epub 2015 Sep 15.

PMID:
26373566
44.

Biomarkers Associated with Vascular Calcification in Peritoneal Dialysis.

Ramirez-Sandoval JC, Casanova I, Villar A, Gomez FE, Cruz C, Correa-Rotter R.

Perit Dial Int. 2016 May-Jun;36(3):262-8. doi: 10.3747/pdi.2014.00250. Epub 2015 Aug 20.

45.

Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers.

Schievink B, de Zeeuw D, Smink PA, Andress D, Brennan JJ, Coll B, Correa-Rotter R, Hou FF, Kohan D, Kitzman DW, Makino H, Parving HH, Perkovic V, Remuzzi G, Tobe S, Toto R, Hoekman J, Lambers Heerspink HJ.

Eur J Prev Cardiol. 2016 May;23(7):758-68. doi: 10.1177/2047487315598709. Epub 2015 Jul 30.

PMID:
26229089
46.

Predictors of Atrasentan-Associated Fluid Retention and Change in Albuminuria in Patients with Diabetic Nephropathy.

Kohan DE, Lambers Heerspink HJ, Coll B, Andress D, Brennan JJ, Kitzman DW, Correa-Rotter R, Makino H, Perkovic V, Hou FF, Remuzzi G, Tobe SW, Toto R, Parving HH, de Zeeuw D.

Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1568-74. doi: 10.2215/CJN.00570115. Epub 2015 Jul 7.

47.

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Drüeke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators*.

Circulation. 2015 Jul 7;132(1):27-39. doi: 10.1161/CIRCULATIONAHA.114.013876. Epub 2015 Jun 9.

PMID:
26059012
48.

The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trial.

Chang TI, Abdalla S, London GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Herzog CA, Mahaffey KW, Moe SM, Parfrey PS, Wheeler DC, Dehmel B, Goodman WG, Chertow GM.

J Hum Hypertens. 2016 Mar;30(3):204-9. doi: 10.1038/jhh.2015.56. Epub 2015 Jun 4.

PMID:
26040438
49.

The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Parfrey PS, Drüeke TB, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Kubo Y, Dehmel B, Goodman WG, Chertow GM; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators.

Clin J Am Soc Nephrol. 2015 May 7;10(5):791-9. doi: 10.2215/CJN.07730814. Epub 2015 Feb 20.

50.

Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial.

Moe SM, Abdalla S, Chertow GM, Parfrey PS, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Dehmel B, Goodman WG, Drüeke TB; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators.

J Am Soc Nephrol. 2015 Jun;26(6):1466-75. doi: 10.1681/ASN.2014040414. Epub 2014 Dec 11.

Supplemental Content

Loading ...
Support Center